Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers

Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study

(2022) Yuhai Chen et al.   Annals of Translational Medicine

The Value of Cytology in the Evaluation of Malignant Pericardial Effusions: A Systematic Review

(2022) Ranim Shartouni et al.   Diagnostics

Immunohistochemistry Applied to Breast Cytological Material

(2022) Daniel Pinto et al.   PATHOBIOLOGY

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study

(2022) Ilias P. Nikas et al.   Cancer Medicine

Epidemiology of Triple-Negative Breast Cancer

(2021) Frederick M. Howard et al.   CANCER JOURNAL

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing

(2021) Konstantinos I. Tsamis et al.   Molecular Diagnosis & Therapy

Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

(2021) Thomas Grinda et al.   npj Breast Cancer

Biomarkers Changes after Neoadjuvant Chemotherapy in Breast Cancer: A Seven-Year Single Institution Experience

(2021) Saverio Coiro et al.   Diagnostics

Malignancies in Pleural, Peritoneal, and Pericardial Effusions: A 17-Year Single-Institution Review From 30 085 Specimens

(2020) Josephine Kam Tai Dermawan et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

(2020) Kimberly H. Allison et al.   JOURNAL OF CLINICAL ONCOLOGY

Receptor Discordance of Metastatic Breast Cancer Depending on the Molecular Subtype

(2020) Iris Holzer et al.   Breast Care

Receptor discordance and phenotype change in metastatic breast cancer

(2020) Jui-Yin Kao et al.   Asian Journal of Surgery

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ancillary Tests in Breast Cytology: A Practical Guide

(2019) Francisco Beca et al.   ACTA CYTOLOGICA

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study

(2019) Akira Matsui   Oncotarget

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

(2018) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Ancillary studies in pleural, pericardial, and peritoneal effusion cytology

(2018) Kaitlin E. Sundling et al.   CANCER CYTOPATHOLOGY

Viewing the Eph receptors with a focus on breast cancer heterogeneity

(2018) Ilias Nikas et al.   CANCER LETTERS

Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology

(2018) Marianne Engels et al.   CYTOPATHOLOGY

Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis

(2017) Jaehag Jung et al.   JOURNAL OF NEURO-ONCOLOGY

Tumour heterogeneity and resistance to cancer therapies

(2017) Ibiayi Dagogo-Jack et al.   Nature Reviews Clinical Oncology

Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy

(2017) Willemijne A.M.E. Schrijver et al.   Oncotarget

Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study

(2016) Issam M. Francis et al.   DIAGNOSTIC CYTOPATHOLOGY

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

(2015) O. Gumusay et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer

(2014) Heae Surng Park et al.   MODERN PATHOLOGY

Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases

(2014) Won-Suk Lee et al.   Cancer Medicine

A new convenient technique for making cell blocks

(2012) Qing-Lian He et al.   CELL AND TISSUE RESEARCH

Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: Correlation of results to corresponding tissue block (needle core and excisi

(2012) Mary D. Kinsella et al.   DIAGNOSTIC CYTOPATHOLOGY

Discordant HER2 Status Between Primary Breast Carcinoma and Recurrent/Metastatic Tumors Using Fluorescence In Situ Hybridization on Cytological Samples

(2012) K. Arihiro et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Heterogeneity in breast cancer

(2011) Kornelia Polyak   JOURNAL OF CLINICAL INVESTIGATION

Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival

(2010) Jung Ah Lee et al.   BREAST CANCER RESEARCH AND TREATMENT

Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma

(2010) Ahmed Shabaik et al.   DIAGNOSTIC CYTOPATHOLOGY

EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

(2009) S. Gori et al.   ANNALS OF ONCOLOGY